Australia markets open in 8 hours 47 minutes

Protalix BioTherapeutics, Inc. (PLX)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
1.1500-0.0300 (-2.54%)
At close: 04:00PM EDT
1.1500 0.00 (0.00%)
After hours: 06:04PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
65,494
65,494
47,638
38,350
62,898
Cost of revenue
22,982
22,982
19,592
16,349
10,873
Gross profit
42,512
42,512
28,046
22,001
52,025
Operating expenses
Research development
17,093
17,093
29,349
29,734
38,167
Selling general and administrative
14,959
14,959
11,711
12,729
11,148
Total operating expenses
32,052
32,052
41,060
42,463
49,315
Operating income or loss
10,460
10,460
-13,014
-20,462
2,710
Interest expense
3,180
3,180
2,529
7,521
9,671
Income before tax
8,566
8,566
-14,397
-27,582
-6,523
Income tax expense
254
254
530
0
-
Income from continuing operations
8,312
8,312
-14,927
-27,582
-6,523
Net income
8,312
8,312
-14,927
-27,582
-6,523
Net income available to common shareholders
8,312
8,312
-14,927
-27,582
-6,523
Basic EPS
0.15
0.12
-0.31
-0.62
-0.22
Diluted EPS
0.09
0.09
-0.31
-0.62
-0.22
Basic average shares
62,144
67,513
48,472
44,140
29,148
Diluted average shares
73,565
82,424
48,472
44,140
29,148